Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 19, 2023 08:56 ET | Source: Neuronetics

Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans

MALVERN, Pa., July 19, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
July 17, 2023 08:46 ET | Source: Neuronetics

NeuroStar Achieves Milestone Regulatory Clearance in South Korea

MALVERN, Pa., July 17, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
July 11, 2023 08:56 ET | Source: Neuronetics

NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player

MALVERN, Pa., July 11, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
June 12, 2023 08:59 ET | Source: Neuronetics

Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy

MALVERN, Pa., June 12, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
May 26, 2023 08:59 ET | Source: Neuronetics

Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan

MALVERN, Pa., May 26, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
May 24, 2023 16:30 ET | Source: Neuronetics

Neuronetics to Present at the William Blair 43rd Annual Growth Stock Conference

MALVERN, Pa., May 24, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or “Neuronetics”), a commercial stage medical technology company with a strategic vision of...
May 23, 2023 08:46 ET | Source: Neuronetics

New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction

MALVERN, Pa., May 23, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
May 15, 2023 08:56 ET | Source: Neuronetics

Neuronetics Wins 2023 Bell Seal for Workplace Mental Health

MALVERN, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
May 09, 2023 17:00 ET | Source: Neuronetics

Neuronetics to Present at the JMP Securities Life Sciences Conference

MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming...
May 09, 2023 07:30 ET | Source: Neuronetics

Neuronetics Reports Record First Quarter 2023 Financial and Operating Results

MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right